NEW BRUNSWICK, N.J. – The Level I Trauma Center at Robert Wood Johnson University Hospital (RWJUH) will host a Distracted Driving Town Hall Meeting on Sept. 27, from 7 to 9 p.m., in The Arline and Henry Schwartzman Courtyard.
The purpose of this event is to raise community awareness of and educate the public about issues created by distracted driving. Distracted driving comes in various forms, such as cell phone use, grooming, eating and use of in-vehicle technologies and portable electronic devices.
According to the U.S. Department of Transportation, nearly 5,500 people died and half a million were injured in 2009 (the most recent year for which statistics are available) in accidents involving a distracted driver.
The New Jersey Legislature is considering distracted driving-related bills (S1950 and A2816), which would establish the violation of hands-free cell phone law as reckless under vehicular homicide statute and assault by auto statutes.
The town hall at RWJUH will feature personal stories of individuals who were directly impacted by distracted drivers.
Special guests include Adam M. Shiroff, M.D., trauma surgeon at the Level I Trauma Center at RWJUH, Edward O’Connor, Regional Supervisor, New Jersey Division of Highway Traffic Safety (NJDHTS), and Pam Fischer, Principal at Pam Fischer Consulting and Coordinator of the NJ Teen Safe Driving Coalition, and Assemblyman Gordon Johnson (D-Bergen), chair of the N.J. State Legislature Assembly Law and Public Safety Committee.
EVENT: Distracted Driving Town Hall
DATE/TIME: Tuesday, Sept. 27, 2011, from 7 to 9 p.m.
LOCATION: Arline and Henry Schwartzman Courtyard
Robert Wood Johnson University Hospital
1 Robert Wood Johnson Pl.
New Brunswick, N.J. 08903
For more information and to register, call 1-888-MD-RWJUH by Sept. 26, 2011.
Reporters interested in attending the Sept. 27 event may contact Peter Haigney or Zenaida Mendez at RWJUH Public Relations - (732) 937-8521.
About Robert Wood Johnson University Hospital
Robert Wood Johnson University Hospital (RWJUH) is a 965-bed academic medical center with campuses in New Brunswick and Somerville, NJ. Its Centers of Excellence include cardiovascular care from minimally invasive heart surgery to transplantation, cancer care, stroke care, neuroscience, joint replacement, and women’s and children’s care including The Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital (www.bmsch.org). As the flagship Cancer Hospital of Rutgers Cancer Institute of New Jersey and the principal teaching hospital of Rutgers Robert Wood Johnson Medical School in New Brunswick, RWJUH is an innovative leader in advancing state-of-the-art care. A Level 1 Trauma Center and the only Pediatric Trauma Center in the state, RWJUH’s New Brunswick campus serves as a national resource in its ground-breaking approaches to emergency preparedness.
RWJUH has been ranked among the best hospitals in America by U.S. News & World Report seven times and has been selected by the publication as a high performing hospital in numerous specialties. The Bristol-Myers Squibb Children’s Hospital has been ranked among the best hospitals in America by U.S. News & World Report for three consecutive years.
Both the New Brunswick and Somerset campuses have earned significant national recognition for clinical quality and patient safety, including the prestigious Magnet® Award for Nursing Excellence, an “A” patient safety rating from the Leapfrog Group and “Most Wired” designation by Hospitals and Health Networks Magazine. The Joint Commission and the New Jersey Department of Health and Senior Services have designated the New Brunswick Campus as a Comprehensive Stroke Center and the Somerset Campus as a Primary Stroke Center.
The American College of Surgeons’ Commission on Cancer has rated RWJUH New Brunswick among the nation’s best comprehensive cancer centers and designated the Steeplechase Cancer Center at RWJ Somerset as a Comprehensive Community Cancer Center. The Joint Surgery Center at Robert Wood Johnson University Hospital Somerset has earned the Joint Commission’s Gold Seal of Approval for total knee and total hip replacement surgery.